About Kaiser Permanente Northwest Region Oncology Hematology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Kaiser Permanente Northwest Region Oncology Hematology
During the past decade, Kaiser Permanente Northwest Region Oncology Hematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 4 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
2008-04-01
2014-07-01
Terminated
3,509
LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment
2010-06-22
2018-07-06
Completed
508
LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures
2011-05-24
2017-03-13
Completed
74
Quality Study of Anesthetic Technique on Breast Cancer Surgery
2012-01-01
2013-06-01
Completed
101
Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects
2011-12-01
2019-08-01
Completed
349
LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy
2012-03-05
2017-12-27
Completed
795
A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study)
2013-10-14
2021-03-05
Completed
431
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Kaiser Permanente Northwest Region Oncology Hematology" #1 sponsor was "Astellas Pharma Inc" with 1 trials, followed by "Gilead Sciences" with 1 trials
sponsored, "Pfizer" with 1 trials sponsored, "Puma Biotechnology, Inc." with 1 trials sponsored and "Threshold Pharmaceuticals"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Kaiser Permanente Northwest Region Oncology Hematology"
#1 collaborator was "Agensys, Inc." with 1 trials as a collaborator and "PRA Health Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Kaiser Permanente Northwest Region Oncology Hematology
According to Clinical.Site data, the most researched conditions in "Kaiser Permanente Northwest Region Oncology Hematology" are
"Breast Cancer" (1 trials), "Carcinoma, Pancreatic Ductal" (1 trials), "Colorectal Cancer" (1 trials), "Metastatic or Unresectable Cutaneous Melanoma" (1 trials) and "Pancreatic Adenocarcinoma" (1 trials). Many other conditions were trialed in "Kaiser Permanente Northwest Region Oncology Hematology" in a lesser frequency.
Clinical Trials Intervention Types at Kaiser Permanente Northwest Region Oncology Hematology
Most popular intervention types in "Kaiser Permanente Northwest Region Oncology Hematology" are "Drug" (4 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "AGS-1C4D4" (1 trials), "Dacarbazine" (1 trials), "Fluorouracil" (1 trials), "Gemcitabine" (1 trials) and "Gemzar (Gemcitabine)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kaiser Permanente Northwest Region Oncology Hematology
The vast majority of trials in "Kaiser Permanente Northwest Region Oncology Hematology" are
4 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Kaiser Permanente Northwest Region Oncology Hematology
Currently, there are NaN active trials in "Kaiser Permanente Northwest Region Oncology Hematology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Kaiser Permanente Northwest Region Oncology Hematology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kaiser Permanente Northwest Region Oncology Hematology, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".